Dosage ; Over 15 years: 10mg TID (over 60kg), 5mg TID (under 60kg).
9-14 years:5mg TID (over 30kg). 5-9 years: 2.5mg TID (20-29kg).
3-5 years: 2mg BD or TID (15-19kg). 1-3 years:1mg BD or TID (10-14kg).
Under 1 year: 1mg BD daily dose should. Not to exceed 0.5/kg/day.
| Brand Name | Manufacturer Name | Distributor | Drug Strength | Packaging | Formulation | Formulation Strength | Price |
|---|---|---|---|---|---|---|---|
| Domide | Dawa Limited | Dawa Limited | 5mg | 60ml | Syrup | per 5ML | KES 45.00 |
| Emeton | Biodeal Laboratories Ltd. | Biodeal Laboratories Ltd. | 5mg | 60ml | Syrup | per 5ML | KES 60.00 |
| Emeton | Biodeal Laboratories Ltd. | Biodeal Laboratories Ltd. | 10mg | 100 doses | Tablet | per tablet | KES 400.00 |
| Gastrolon | Efroze Chemical Industries Ltd | Njimia Pharmaceuticals Ltd. | 10mg | 100 | Tablet | per tablet | KES 151 |
| Melasil | Laboratory & Allied Ltd. | Laboratory & Allied Ltd | 10mg | 100 | Tablet | per tablet | KES 53.00 |
| Melasil | Laboratory & Allied Ltd. | Laboratory & Allied Ltd | 10mg | 1000 | Tablet | per tablet | KES 325.00 |
| Melasil | Laboratory & Allied Ltd. | Laboratory & Allied Ltd | 5mg | 1 | Injection | per vial | KES 12.00 |
| Melasil | Laboratory & Allied Ltd. | Laboratory & Allied Ltd | 5mg | 100ml | Syrup | per 5ML | KES 32.oo |
| Metcos | Cosmos Limited. | Cosmos Limited | 10mg | 100 | Tablet | per tablet | KES 100.00 |
| Perinorm | IPCA | Sai Pharmaceuticals Ltd. | 5mg | 10 | Injection | per ml | KES 146 |
| Primperan | Sanofi Aventis | Surgipharm Ltd | 10mg | 20 | Tablet | per tablet | KES 456 |
| Primperan | Sanofi Aventis | Surgipharm Ltd | 5mg | 12 | Injection | per ml | KES 435 |
| Cloperan | Remedica Ltd. | Twokay Chemicals Ltd | 10mg | 100 | Tablet | per tablet | KES 400.00 |
| Metoclon | Indus Pharma | Globe Pharmacy Ltd., | 10mg | 2ml | Injection | per vial | KES 11.70 |
| Metopride | Prism Life Sciences | Galaxy Pharmaceuticals Ltd | 10mg | 2ml | infusion | per ml | KES 12.00 |
|
Metoclopramide More info |
|
|---|---|
| Drug Indication | Digestive disorders associated with gastrointestinal stasis, hypomotility, drug induced vomiting, emetic disorders; facilitation of the intestinal intubation in adults and children; stimulation of gastric emptying and intestinal transit of barium in cases where delayed; persistent hiccups. |
| Precautions | Parkinsonism; young patients; concomitant use with medicines that cause extrapyramidal side effects; total daily dose should not exceed 0.5mg/kg BM; prolonged therapy; those at risk of fluid retention; renal impairment; elderly. |
| Contra-Indications | Phaeochromocytoma: may cause a hypertensive crisis; not to be used when stimulation of GI motility might be dangerous (e.g., in case of GI haemorrhage; mechanical obstruction, or perforation); known sensitivity or intolerance to the drug; epileptics or patients receiving other drugs that can cause extrapyramidal reactions. |
| Side Effects | Extrapyramidal effects; CNS effects; GI disturbances; peri-orbital oedema; skin rash; galactorrhoea; gynaecomastia; breast engorgement; impotence; amenorrhoea; tardive dyskinesia; restlessness; drowsiness. |
| Dosage | Over 15 years: 10mg TID (over 60kg), 5mg TID (under 60kg). 9-14 years:5mg TID (over 30kg). 5-9 years: 2.5mg TID (20-29kg). 3-5 years: 2mg BD or TID (15-19kg). 1-3 years:1mg BD or TID (10-14kg). Under 1 year: 1mg BD daily dose should. Not to exceed 0.5/kg/day. |
| Pregnancy Category | Category A1: |
| Pregnancy Category Description | Drugs which have been taken by a sizeable number of pregnant women and women of child-bearing age with no any established rise in the frequency of malformations or other direct or indirect detrimental effects on the foetus having been noted. |
| Drug Sub-Category | Motility stimulants
Dosing: Adult Gastroesophageal reflux: Oral: 10-15 mg/dose up to 4 times/day 30 minutes before meals or food and at bedtime; single doses of 20 mg are occasionally needed prior to provoking situations. Treatment >12 weeks is not recommended. Diabetic gastroparesis: Oral: 10 mg/dose up to 4 times/day 30 minutes before meals or food and at bedtime for 2-8 weeks I.M., I.V. (for severe symptoms): 10 mg over 1-2 minutes; 10 days of I.V. therapy may be necessary before symptoms are controlled to allow transition to oral administration Chemotherapy-induced emesis prophylaxis: I.V.: 1-2 mg/kg 30 minutes before chemotherapy and repeated every 2 hours for 2 doses, then every 3 hours for 3 doses (manufacturer labeling); pretreatment with diphenhydramine will decrease risk of extrapyramidal reactions Alternate dosing: Note: Metoclopramide is considered an antiemetic with a low therapeutic index; use is generally reserved for agents with low emetogenic potential or in patients intolerant/refractory to first line antiemetics. Low-risk chemotherapy (unlabeled): I.V., Oral: 10-40 mg prior to dose, then every 4-6 hours as needed (NCCN Antiemesis guidelines, v.4.2009) Breakthrough treatment (unlabeled): I.V., Oral: 10-40 mg every 4-6 hours (NCCN Antiemesis guidelines, v.4.2009) Delayed-emesis prophylaxis (unlabeled): Oral: 20-40 mg/dose (or 0.5 mg/kg/dose) 2-4 times/day for 3-4 days (in combination with dexamethasone [ASCO guidelines, 2006]) Refractory or intolerant to antiemetics with a higher therapeutic index (unlabeled; Hesketh, 2008): I.V.: 1-2 mg/kg/dose before chemotherapy and repeat 2 hours after chemotherapy Oral: 0.5 mg/kg every 6 hours on days 2-4 Postoperative nausea and vomiting prophylaxis: I.M., I.V. (unlabeled route): 10-20 mg near end of surgery. Note: Guidelines discourage use of 10 mg metoclopramide as being ineffective (Gan, 2007); comparative study indicates higher dose (20 mg) may be efficacious (Quaynor, 2002). Postpyloric feeding tube placement, radiological exam: I.V.: 10 mg as a single dose Dosing: Pediatric (For additional information see "Metoclopramide: Pediatric drug information") Gastroesophageal reflux (unlabeled use): Oral: 0.1-0.2 mg/kg/dose 4 times/day (maximum: 5 doses/day); pretreatment with diphenhydramine will decrease risk of extrapyramidal reactions to this dosage Chemotherapy-induced emesis (unlabeled use): I.V.: 1-2 mg/kg 30 minutes before chemotherapy and every 2-4 hours Postpyloric feeding tube placement: I.V.: <6 years: 0.1 mg/kg as a single dose 6-14 years: 2.5-5 mg as a single dose >14 years: Refer to adult dosing. Dosing: Geriatric Initial: Dose at the lower end of the recommended range. Refer to adult dosing. Dosing: Renal Impairment Clcr <40 mL/minute: Administer 50% of normal dose. Not dialyzable (0% to 5%); supplemental dose is not necessary |